Posted in | News | Nanobusiness

$40,000 "Outstanding Creative Capability Award" Goes To American Nano Silicon Technology For Further Product Development

After a corporate name change earlier this month American Nano Silicon Technology, Inc. has announced that the Company won a RMB 300,000 Yuan (US$40,000) "Outstanding Creative Capability Award" conferred by the Sichuan Provincial Economic and Trade Commission. The objective of the award is to identify and support small and mid-sized enterprises with significant growth potential and new proprietary products. It aims to encourage these enterprises to boost their research and development efforts further, so as to build their brand names with patented technologies.

The Company intends to use the award funds to expand its Technology R&D Center and further improve and upgrade its nationally patented Micro Silicon Nano™ Technology. "We are pleased and honored to win this award. It is recognition of our Company's unswerving efforts to raise the standards of creativity in our industry, and our mission to develop more and more creative products to meet the needs of our customers," commented Mr. Pu Fachun, Chairman of the Company.

American Nano Silicon Technology, Inc., through its 95%-owned subsidiary, Nanchong Chunfei Nano Silicon Technologies Co., Ltd., located in Sichuan Province in Southwest China, is engaged in the business of manufacturing and distributing refined consumer chemical products across China through its subsidiary, Chunfei Chemicals, and veterinary drugs through another subsidiary, Hedi Medicines.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.